Cost-effectiveness of testing for Mycoplasma genitalium among men who have sex with men in Australia

Conclusion
Testing only symptomatic MSM is the most cost-effective option, even when the potential costs associated with AMR are accounted for (up to $150 additional cost per antibiotic given). For pathogens like MG, where there are anticipated future costs related to AMR, we recommend models that test the impact of incorporating an AMR tax as they can change the results and conclusions of cost-effectiveness studies.

Source: Sexually Transmitted Infections - August 17, 2023 Category: Sexual Medicine Authors: Ong, J. J., Lim, A., Bradshaw, C., Taylor-Robinson, D., Unemo, M., Horner, P. J., Vickerman, P., Zhang, L. Tags: Original research Source Type: research